| [Code of Federal Regulations] |
| [Title 21, Volume 5] |
| [Revised as of April 1, 2009] |
| [CITE: 21CFR314.630] |
|
|
CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES |
|
| SUBCHAPTER D--DRUGS FOR HUMAN USE |
|
PART 314 -- APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
Subpart I--Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible
|
Sec. 314.630 Postmarketing safety reporting.
|
|
Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in 314.80 and 314.81.
|
|